|
ViiV Healthcare is a pharmaceutical company specialising in the development of therapies for HIV that was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company.〔Jacks, Andrew ("GSK and Pfizer to merge HIV portfolios ) Financial Times. 16 April 2010 〕 In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. This ownership structure may change depending upon the achievement of certain milestones.〔 ViiV Healthcare's products have a market share of approximately 19 percent〔("ViiV company website – about us" ) Accessed 13 October 2010〕 of the global HIV market, which makes it the second largest health care company, following after Gilead Sciences, that is working on the treatment of HIV.〔Jacks, Andrew ("ViiV vows joint venture will help fight HIV" ) Financial Times. 3 November 2009 〕 ViiV Healthcare's headquarters are in Brentford in the United Kingdom and it has sites in a number of other countries including; the United States, Australia, Belgium, Canada, France, Germany, Italy, Japan, Mexico, the Netherlands, Portugal, Puerto Rico, Russia, Spain and Switzerland.〔("ViiV company website – about us" ) Accessed 13 October 2010〕 ==Products== The company currently markets 12 products:〔("ViiV company website – products" ) Accessed 13 October 2010〕〔McNeil, Donald ("AIDS Divisions of 2 Large Drug Makers Form Company to Focus on the Disease" ) New York Times. 9 November 2009〕 * Combivir (lamivudine/zidovudine) * Epivir (lamivudine) * Epzicom, Kivexa (abacavir/lamivudine) * Lexiva, Telzir (fosamprenavir) * Rescriptor (delavirdine) * Retrovir (zidovudine) * Selzentry, Celsentri (maraviroc) * Tivicay (dolutegravir) * Triumeq (abacavir/dolutegravir/lamivudine) * Trizivir (abacavir/lamivudine/zidovudine) * Viracept (nelfinavir) * Ziagen (abacavir) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「ViiV Healthcare」の詳細全文を読む スポンサード リンク
|